Simple Summary Breast cancer is the most common cancer among women. It is estimated
that 2.3 million new cases of BC are diagnosed globally each year. Based on mRNA gene …

Introduction The selective estrogen receptor degrader (SERD) and full receptor antagonist
provides an important therapeutic option for hormone receptor (HR)-positive breast cancer …

Background: breast cancer is the most common cause of cancer death for women
worldwide. In the past two decades, published epidemiological reports in different parts of …

Objective Cancer incidence and mortality rates in Africa are increasing, yet their geographic
distribution and determinants are incompletely characterized. The present study aims to …

This study aimed to evaluate the global incidence and mortality trends of breast cancer
among females by region and age in the past decade. We retrieved country-specific …

Purpose This study aims to examine the burden of breast cancer in 185 countries in 2018.
Methods The estimates of incidence, mortality, and prevalence of breast cancer were drawn …

Simple Summary The breakthrough of immunotherapy in melanoma has generated a
glimmer of hope for lethal triple negative breast cancer (TNBC). This review summarizes the …

Objectives This study aimed to evaluate the most updated worldwide distribution, risk
factors, and temporal trends of cervical cancer for different countries and age groups …

Importance Breast cancer is the most prevalent cancer globally with tremendous disparities
both within specific regions and across different contexts. The survival pattern of patients …

Background: Female breast cancer (FBC) has become the most prevalent malignancy
worldwide. We aimed to evaluate the global and regional burden in epidemiological trends …